Brucen's extract said...
Prolonged treatment with corticosteroids was associated with the development of numerous granulomata, stricturing, and perianal disease.
It is speculated that the immunosuppression associated with the corticosteroid treatment may have induced a change from ulcerative colitis to Crohn's disease of the colon.
Corticosteroids might not only change UC to Crohn's but there is research indicating that those who were prescribed steroids have dramatically lower rates of spontaneous remission. Almost all patients with IBD undergo standard medical care (drugs) but there are some patients in clinical trials who are in the placebo group, i.e. not on meds.
The National Cooperative Crohn's Disease Study (NCCDS) reviewed 77 patients who received placebo therapy. They all had active disease as defined by the CDAI index greater than 150. After 17 weeks of placebo therapy (no drugs) 49 percent were found to have a CDAI lower than 150. None of these patients' intestinal X-rays showed worsening of the disease. The majority (70 percent) remained in remission for one year and 45 percent remained in remission after two years.
However for those patients in the placebo group who had no history of steroid therapy 41 percent achieved remission after 17 weeks and 23 percent continued in remission after two years,
compared with only a 4 percent of the group with a history of steroid use.Similar results were found in the European Cooperative Crohn's Disease Study (ECCDS) in their study with 110 patients in the placebo group. Like the NCCDS, the ECCDS demonstrated that patients with no prior drug therapy have a greater likelihood of remission.
Although researchers did not advocate placebo therapy, they did carefully point that once remission is achieved, 75% of patients can continue in remission after one year and up to 63% for two years. Apparently the key is achieving remission which once attained, can be maintained by conservative nondrug therapy.